(VIANEWS) – ITT Educational Services (ESI), SpartanNash Company (SPTN), Bristol (BMY) are the highest payout ratio stocks on this list.
We have congregated information concerning stocks with the highest payout ratio so far. The payout ratio in itself isn’t a guarantee of good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here are a few stocks with an above 30% percent payout ratio.
1. ITT Educational Services (ESI)
152.38% Payout Ratio
Element Solutions Inc operates as a specialty chemicals company in the United States, China, and internationally. The company operates in two segments, Electronics, and Industrial & Specialty. The Electronics segment researches, formulates, and sells specialty chemicals and materials for various types of electronics hardware products. This segment also supplies solder technologies, fluxes, cleaners, and other attachment materials for the electronics assembly industry; proprietary liquid chemical processes to manufacture printed circuit boards; and advanced copper interconnects, die attachment, wafer bump processes, and photomask technologies for integrated circuit fabrication and semiconductor packaging. It primarily serves mobile communications, computers, automobiles, and aerospace equipment industries. The Industrial & Specialty segment provides industrial solutions, which include chemical systems that protect and decorate metal and plastic surfaces; consumable chemicals that enable printing image transfer on flexible packaging materials; and chemistries used in water-based hydraulic control fluids for offshore energy production applications. It serves aerospace, automotive, construction, consumer electronics, consumer packaged goods, and oil and gas production end markets. The company was formerly known as Platform Specialty Products Corporation and changed its name to Element Solutions Inc in January 2019. Element Solutions Inc was founded in 1785 and is headquartered in Fort Lauderdale, Florida.
Earnings Per Share
As for profitability, ITT Educational Services has a trailing twelve months EPS of $0.21.
PE Ratio
ITT Educational Services has a trailing twelve months price to earnings ratio of 108.71. Meaning, the purchaser of the share is investing $108.71 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.24%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.1%, now sitting on 2.33B for the twelve trailing months.
2. SpartanNash Company (SPTN)
70.08% Payout Ratio
SpartanNash Company distributes and retails grocery products. It operates in three segments: Food Distribution, Military, and Retail. The Food Distribution segment offers approximately 68,000 stock-keeping units, such as dry groceries, produce, dairy products, meat, delicatessen items, bakery goods, frozen food, seafood, floral products, general merchandise, beverages, tobacco products, health and beauty care, and pharmacy products to independent retailers, national retailers, food service distributors, e-commerce providers, and corporate owned retail stores. This segment also offers various value-added services to retailers. The Military segment sells and distributes grocery products to 160 military commissaries and approximately 400 exchanges located in 39 states across the United States and the District of Columbia, Europe, Cuba, Puerto Rico, Honduras, Bahrain, Djibouti, and Egypt. The Retail segment primarily operates neighborhood markets. As of March 11, 2021, it operated 154 supermarkets, primarily under the banners of Family Fare, Martin's Super Markets, D&W Fresh Market, VG's Grocery, and Dan's Supermarket. SpartanNash Company also markets and distributes private brand items primarily under the Our Family brand name. The company was formerly known as Spartan Stores, Inc. and changed its name to SpartanNash Company in November 2013. SpartanNash Company was founded in 1917 and is headquartered in Grand Rapids, Michigan.
Earnings Per Share
As for profitability, SpartanNash Company has a trailing twelve months EPS of $1.22.
PE Ratio
SpartanNash Company has a trailing twelve months price to earnings ratio of 18.65. Meaning, the purchaser of the share is investing $18.65 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.47%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 46.4% and 4.7%, respectively.
Earnings Before Interest, Taxes, Depreciation, and Amortization
SpartanNash Company’s EBITDA is 33.62.
Volume
Today’s last reported volume for SpartanNash Company is 174668 which is 29.11% below its average volume of 246422.
3. Bristol (BMY)
57.87% Payout Ratio
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, and neuroscience diseases. The company's products include Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; Orencia for adult patients with active RA and psoriatic arthritis; and Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of multiple myeloma; Abecma for the treatment of relapsed or refractory multiple myeloma; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Onureg for the treatment of adult patients with AML; Inrebic, an oral kinase inhibitor indicated for the treatment of myelofibrosis; Camzyos for the treatment of adults with symptomatic obstructive HCM to enhance functional capacity and symptoms; Sotyktu for the treatment of adults with moderate-to-severe plaque psoriasis; Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; and Abraxane, a protein-bound chemotherapy product. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Bristol has a trailing twelve months EPS of $3.94.
PE Ratio
Bristol has a trailing twelve months price to earnings ratio of 12.35. Meaning, the purchaser of the share is investing $12.35 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 26.87%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is a negative 11% and a negative 10.7%, respectively.
Volume
Today’s last reported volume for Bristol is 13558100 which is 10.39% below its average volume of 15130900.
Yearly Top and Bottom Value
Bristol’s stock is valued at $48.65 at 01:23 EST, way under its 52-week high of $75.18 and higher than its 52-week low of $48.25.
Previous days news about Bristol (BMY)
- Wall street's insights into key metrics ahead of bristol myers (bmy) Q4 earnings. According to Zacks on Tuesday, 30 January, "Wall Street analysts forecast that Bristol Myers Squibb (BMY Quick QuoteBMY – Free Report) will report quarterly earnings of $1.56 per share in its upcoming release, pointing to a year-over-year decline of 14.3%. ", "Bearing this in mind, let’s now explore the average estimates of specific Bristol Myers metrics that are commonly monitored and projected by Wall Street analysts."
- According to Zacks on Wednesday, 31 January, "2seventy bio and Bristol Myers (BMY Quick QuoteBMY – Free Report) are jointly developing and commercializing Abecma in the United States.", "2seventy bio, along with Bristol Myers, remains focused on supporting a potential third-line launch of Abecma later this year."
- Bristol myers' (bmy) sblas for breyanzi get FDA priority tag. According to Zacks on Wednesday, 31 January, "Shares of Bristol Myers have plunged 30.6% in the past year compared with the industry’s decline of 12%.", "The approval of new drugs and label expansion of existing ones will enable Bristol Myers to diversify its product base and drive top-line growth in the days ahead."
4. Acco Brands Corporation (ACCO)
51.72% Payout Ratio
ACCO Brands Corporation designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, calendars, planners, dry erase boards, and janitorial supplies; storage and organization products, such as three-ring and lever-arch binders, sheet protectors, and indexes; laminating, binding, and shredding machines; writing instruments; stapling and punching products; do-it-yourself tools; and computer accessories and others used in schools, homes, and businesses. It offers its products primarily under the AT-A-GLANCE, Barrilito, Derwent, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Marbig, Mead, NOBO, Quartet, Rapid, Rexel, Swingline, Tilibra, Spirax, and Wilson Jones brand names. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, drug/grocery, and variety chains; warehouse clubs; hardware and specialty stores; independent office product dealers; office superstores; wholesalers; and contract stationers, as well as sells products directly to commercial and consumer end-users through its e-commerce platform and direct sales organization. ACCO Brands Corporation was founded in 1893 and is headquartered in Lake Zurich, Illinois.
Earnings Per Share
As for profitability, Acco Brands Corporation has a trailing twelve months EPS of $0.58.
PE Ratio
Acco Brands Corporation has a trailing twelve months price to earnings ratio of 10.59. Meaning, the purchaser of the share is investing $10.59 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.97%.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 1% and 1%, respectively.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend rate is 1 and the estimated forward annual dividend yield is 1%.
